Co-amilozide (BAN) is a non-proprietary combinationofamiloride and hydrochlorothiazide. Co-amilozide is used in the treatment of hypertension and congestive heart failure with the tendency of the thiazide to cause low potassium levels (hypokalaemia) offset by the potassium-sparing effects of amiloride.
| Combination of | |
|---|---|
| Amiloride | Potassium-sparing diuretic |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| CompTox Dashboard (EPA) | |
| (verify) | |
Two strengths of co-amilozide are currently available in the UK:[1]
In North America:
The most common side effect is headache (about 8% of people taking it) and nausea, loss of appetite, weakness, rash and dizziness (each about 3%).[2]
Common side effects (1/10 - 1/100) include:[2]
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
